METHYS Dx develops innovative liquid biopsy tests for non-invasive monitoring of cancer patients. Combining unique proprietary molecular signatures and a disruptive ultrasensitive detection technology, METHYS Dx tests will allow monitoring of tumor evolution, and early detection of relapses, thus improving patient care through better-informed therapeutic decisions.

METHYS Dx

Office 67 at 67, rue Saint Jacques focuses on research and development, account management, and scientific innovation.

Magali Droniou

This department focuses on innovating and developing new products and technologies.

Research and Development

This department focuses on the analysis and interpretation of biological data using computational tools and methods.

Bioinformatics Division

This department focuses on high-level strategic direction and scientific innovation within the organization.

Executive Leadership

This department manages communications and relationships with private investors to foster engagement and support for investment opportunities.

Investor Relations

This department focuses on guiding and overseeing strategic projects and committee activities to drive organizational goals.

METHYS Dx

Org chart

Teams

Research and Development

Bioinformatics Division

Executive Leadership

Investor Relations

Strategic Initiatives

Offices

METHYS Dx

Org chart

Teams

Research and Development

Bioinformatics Division

Executive Leadership

Investor Relations

Strategic Initiatives

Offices

Related companies